HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 63 filers reported holding HARPOON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $533 | -96.8% | 752 | -96.7% | 0.00% | – |
Q1 2023 | $16,702 | +875.0% | 22,449 | +850.0% | 0.00% | – |
Q4 2022 | $1,713 | -14.4% | 2,363 | +14.3% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 2,067 | +79.7% | 0.00% | – |
Q2 2022 | $2,000 | -91.7% | 1,150 | -76.3% | 0.00% | – |
Q1 2022 | $24,000 | -66.7% | 4,846 | -49.0% | 0.00% | – |
Q4 2021 | $72,000 | -23.4% | 9,495 | -20.5% | 0.00% | – |
Q3 2021 | $94,000 | +13.3% | 11,937 | +99.8% | 0.00% | – |
Q2 2021 | $83,000 | -60.5% | 5,973 | -40.8% | 0.00% | – |
Q1 2021 | $210,000 | +180.0% | 10,093 | +123.1% | 0.00% | – |
Q4 2020 | $75,000 | -5.1% | 4,524 | -3.0% | 0.00% | – |
Q3 2020 | $79,000 | -23.3% | 4,664 | -25.5% | 0.00% | – |
Q2 2020 | $103,000 | +17.0% | 6,257 | -17.9% | 0.00% | – |
Q1 2020 | $88,000 | -24.8% | 7,625 | -3.7% | 0.00% | – |
Q4 2019 | $117,000 | +101.7% | 7,917 | +82.7% | 0.00% | – |
Q3 2019 | $58,000 | +141.7% | 4,334 | +132.4% | 0.00% | – |
Q2 2019 | $24,000 | +380.0% | 1,865 | +270.0% | 0.00% | – |
Q1 2019 | $5,000 | – | 504 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |